We are live on
!
Find out more
AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
46 hedge funds and large institutions have $63.4M invested in Agile Therapeutics in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,900% more call options, than puts
Call options by funds: $40K | Put options by funds: $1K
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 45 → 46 (+1)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
3% less capital invested
Capital invested by funds: $65.5M → $63.4M (-$2.06M)
Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
1.05%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
6
Increased
13
Reduced
13
Closed
5
Calls
$40K
Puts
$1K
Net Calls
+$39K
Net Calls Change
-$233K
Top Buyers
| 1 |
JGC
J. Goldman & Co
New York
|
+$1.93M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$1.61M |
| 3 |
PA
Perceptive Advisors
New York
|
+$496K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$304K |
| 5 |
Renaissance Technologies
New York
|
+$278K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$964K |
| 2 |
RA
Royce & Associates
New York
|
-$793K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$483K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$469K |
| 5 |
Barclays
London,
United Kingdom
|
-$205K |
